Clinical Trials Browser

Completed × INDUSTRY × Sarcoma, Clear Cell × Clear all

NCT04593758 2023-05-24

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Phase 1/2 Completed

Sarcoma, Clear Cell

NCT00557609 2013-02-08

Phase 2 Study in Patients With MiT Tumors

Phase 2 Completed

GenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part